Management of iron deficiency anemia in Indian women using ferric carboxymaltose: a sub-group analysis from the PROMISE multi-center real-world study in India
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20251225Keywords:
Anemia, Efficacy, Females, Ferric carboxymaltose, India, Iron deficiency, Safety, WomenAbstract
Background: To evaluate the effectiveness of intravenous ferric carboxymaltose (FCM) in patients with iron deficiency anaemia (IDA) across 269 centres in India, we conducted a retrospective, observational, real-world investigation. The present analysis was done to evaluate FCM in Indian women with IDA in a real-world scenario.
Methods: Haematological parameters were examined for the study population's baseline and 4±1 week follow-up data on females with anaemia who regularly received FCM for anaemia management.
Results: 1666 females with IDA, the hematological parameters improved significantly at 4 weeks (p<0.001) Hb increased by 2.78 g/dl, serum ferritin increased by 35.26 µg/l, haematocrit, red blood cell (RBC) count, mean corpuscular haemoglobin (MCH) and mean corpuscular volume (MCV). Subjects with severe IDA (n=304), significant increase in Hb (by 3.32 g/dl), serum ferritin (by 34.96 µg/l) (p<0.001 for both), RBC count (p<0.001), haematocrit (p=0.004), MCH (p<0.001) at 4 weeks. Subjects with moderate IDA (n=1227), significant increase in Hb (by 2.66 g/dl), serum ferritin (by 35.42 µg/l), haematocrit, RBC count, MCH and MCV (p<0.001 for all) at 4 weeks. Subjects with mild IDA (n=26), significantly higher mean Hb values were seen at 4 weeks (by 1.99 g/dl) Hematological parameters improved compared to baseline at 4 weeks mean difference was statistically insignificant. Physicians rated efficacy and safety of FCM as very good to good in 97.4% and 97.1% of subjects, respectively.
Conclusions: FCM corrects anemia in all subsets of Indian women in short span of 4 weeks and thus supports evidence of efficacy and safety.
Metrics
References
Gardner W, Kassebaum N. Global, Regional and National Prevalence of Anemia and Its Causes in 204 Countries and Territories, 1990–2019. Current Developments in Nutrition. 2020;4(2):830. DOI: https://doi.org/10.1093/cdn/nzaa053_035
Shukla A. NFHS 2019-21: Anemia rising across all age-groups, fertility rate falls below replacement rate for first time. Available at: cnbctv.com. Accessed on 21 December 2024.
Ministry of Health and Family Welfare, Government of India. Anemia Mukt Bharat: Intensified National Iron Plus Initiative (I-NIPI): Operational Guidelines for Programme Managers. 2018.
Kalaivani K, Ramachandran P. Time trends in prevalence of anaemia in pregnancy. Indian J Med Res. 2018;147(3):268-77. DOI: https://doi.org/10.4103/ijmr.IJMR_1730_16
Sharma A. Eliminating Female Anaemia in India: Prevalence, Challenges and Way Forward. 2022.
Kant S. Do we have a magic bullet to treat moderate and severe anemia in pregnant women. Indian J of Pub Health. 2019;63(3):165. DOI: https://doi.org/10.4103/ijph.IJPH_409_19
Seid MH, Butcher AD, Chatwani A. Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia. Anemia. 2017;2:9642027. DOI: https://doi.org/10.1155/2017/9642027
Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications. Am Fam Physician. 2011;83(6):719-24.
Cotter J, Baldaia C, Ferreira M, Macedo G, Pedroto I. Diagnosis and treatment of iron-deficiency anemia in gastrointestinal bleeding: A systematic review. World J Gastroenterol. 2020;26(45):7242-57. DOI: https://doi.org/10.3748/wjg.v26.i45.7242
Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion. 2009;49(12):2719-28. DOI: https://doi.org/10.1111/j.1537-2995.2009.02327.x
Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol. 2007;110(2):267-78. DOI: https://doi.org/10.1097/01.AOG.0000275286.03283.18
Kaur R, Kant S, Haldar P. Single dose of intravenous ferric carboxymaltose prevents anemia for 6 months among moderately or severely anemic postpartum women: a case study from India. Current Developments in Nutrition. 2021;5(7):78. DOI: https://doi.org/10.1093/cdn/nzab078
Mishra V, Verneker R, Gandhi K, Choudhary S, Lamba S. Iron Deficiency Anemia with Menorrhagia: Ferric Carboxymaltose a Safer Alternative to Blood Transfusion. J Midlife Health. 2018;9(2):92-6. DOI: https://doi.org/10.4103/jmh.JMH_121_17
Rathod S, Samal SK, Mahapatra PC, Samal S. Ferric carboxymaltose: A revolution in the treatment of postpartum anemia in Indian women. Int J Appl Basic Med Res. 2015;5(1):25-30. DOI: https://doi.org/10.4103/2229-516X.149230
Naqash A, Ara R, Bader GN. Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials. BMC Women’s Health. 2018;18(1):6. DOI: https://doi.org/10.1186/s12905-017-0506-8
Kant S, Kaur R, Ahamed F, Singh A, Malhotra S, Kumar R. Effectiveness of intravenous ferric carboxymaltose in improving hemoglobin level among postpartum women with moderate-to-severe anemia at a secondary care hospital in Faridabad, Haryana - An interventional study. Indian J Public Health. 2020;64(2):168-72. DOI: https://doi.org/10.4103/ijph.IJPH_85_19
Sharma N, Thiek JL, Natung T, Ahanthem SS. Comparative Study of Efficacy and Safety of Ferric Carboxymaltose Versus Iron Sucrose in Post-partum Anaemia. J Obstet Gynaecol India. 2017;67(4):253-7. DOI: https://doi.org/10.1007/s13224-017-0971-x
Christoph P, Schuller C, Studer H, Irion O, De Tejada BM, Surbek D. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. J Perinat Med. 2012;40(5):469-74. DOI: https://doi.org/10.1515/jpm-2011-0231
Charmila A, Natarajan S, Chitra TV. Efficacy and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia: A Multi-Center Real-World Study from India. JBM. 2022;13:303-13. DOI: https://doi.org/10.2147/JBM.S361210
WHO. WHO: Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization. 2011.
Singhal R. Burden of Anemia Among Indian Women: A Systematic Review and Meta-Analysis of Literature. Value in Health. 2015;18(7):661-2. DOI: https://doi.org/10.1016/j.jval.2015.09.2403
Sunuwar DR, Singh DR, Chaudhary NK, Pradhan PMS, Rai P, Tiwari K. Prevalence and factors associated with anemia among women of reproductive age in seven South and Southeast Asian countries: Evidence from nationally representative surveys. PLOS ONE. 2020;15(8):236449. DOI: https://doi.org/10.1371/journal.pone.0236449
Khokhar K. Anaemia ‘a silent killer’ among Women in India: Present Scenario. 2012.
Sedlander E, Talegawkar S, Ganjoo R, et al. How gender norms affect anemia in select villages in rural Odisha, India: A qualitative study. Nutrition. 2021;86:111159. DOI: https://doi.org/10.1016/j.nut.2021.111159
Favrat B, Balck K, Breymann C, et al. Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study. PLoS One. 2014;9(4):94217. DOI: https://doi.org/10.1371/journal.pone.0094217
Gupte SA, Venkataraman G, Shah AS, Mudholkar AS, Jangam SM. Clinical effects and safety of ferric carboxymaltose in pregnancy: An Indian real-life experience. J of Obst and Gynaecol Res 2021;47(10):3464-70. DOI: https://doi.org/10.1111/jog.14956
Kapil U, Kapil R, Gupta A. National Iron Plus Initiative: Current status & future strategy. Indian J Med Res. 2019;150(3):239-47. DOI: https://doi.org/10.4103/ijmr.IJMR_1782_18
Rai RK, Fawzi WW, Barik A, Chowdhury A. The burden of iron-deficiency anaemia among women in India: how have iron and folic acid interventions fared? WHO South-East Asia J of Pub Health. 2018;7(1):18. DOI: https://doi.org/10.4103/2224-3151.228423
Damineni SC, Thunga S. IV Ferric Carboxymaltose Vs Oral Iron in the Treatment of Post-partum Iron Deficiency Anaemia. J Clin Diagn Res. 2016;10(11):8-10. DOI: https://doi.org/10.7860/JCDR/2016/19375.8937
Vanobberghen F, Lweno O, Kuemmerle A. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial. The Lancet Global Health. 2021;9(2):189-98. DOI: https://doi.org/10.1016/S2214-109X(20)30448-4
Wani S, Noushad M, Ashiq S. Regain study: retrospective study to assess the effectiveness, tolerability and safety of ferric carboxymaltose in the management of iron deficiency anemia in pregnant women. Anemia. 2019;2:4640635. DOI: https://doi.org/10.1155/2019/4640635
Khalafallah AA, Hyppa A, Chuang A. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy. Semin Hematol. 2018;55(4):223-34. DOI: https://doi.org/10.1053/j.seminhematol.2018.04.006
Downloads
Published
How to Cite
Issue
Section
